Expand GLUE Menu
GLUE MENU

GLUE Stock Posts


Unusual Option Volume

GLUE Monte Rosa Therapeutics24.25+8.24 (+51.5%)

Monte Rosa Therapeutics trades 2,387 contracts. The company has the following event: Live Conference Call and Webcast on Jan 7, 2026. News: Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects
GLUE stock increases 8.7% after hours.

After Hours Gainer

GLUE Monte Rosa Therapeutics16.01+1.61+11.2%

After Hours:17.40+1.39 (+8.7%)

Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results

Globe NewswireTue, 6-Jan 4:05 PM

GLUE stock increases 8.6% after hours.

After Hours Gainer

GLUE Monte Rosa Therapeutics16.01+1.61+11.2%

After Hours:17.38+1.37 (+8.6%)

Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results

Globe NewswireTue, 6-Jan 4:05 PM

Unusual Option Volume

GLUE Monte Rosa Therapeutics16.01+1.61 (+11.2%)

After Hours:16.35+0.34 (+2.1%)

Monte Rosa Therapeutics trades 2,463 contracts. The highest volume is in the 16-Jan-26 17.5 calls, which is 9.3% above the current price. News: Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
Unusual Option Volume

GLUE Monte Rosa Therapeutics6.58+0.11 (+1.7%)

Monte Rosa Therapeutics trades 2,357 contracts.
Unusual Option Volume

GLUE Monte Rosa Therapeutics6.51-0.42 (-6.1%)

Monte Rosa Therapeutics trades 2,387 contracts.
Market Data Delayed 15 Minutes